Alpha DNA Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Alpha DNA Investment Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33,297	Closed	-$524K	–	258
2024 Q1	$524K	Buy	+33,297	New	+$512K	0.19%	131
2021 Q2	–	Sell	-3	Closed	–	–	699
2021 Q1	$0	Sell	3 -11,691	-100%	-$544K	﹤0.01%	798
2020 Q4	$667K	Buy	+11,694	New	+$693K	0.71%	65

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Alpha DNA Investment Management's DCPH Position: Q2 2024 in Review

Alpha DNA Investment Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 33,297 shares — an estimated $524K sold.

Alpha DNA Investment Management first reported a position in DCPH in Q4 2020 and held it in 3 quarters. The position peaked at $667K in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Alpha DNA Investment Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Alpha DNA Investment Management sold 33,297 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $524K.
Alpha DNA Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Alpha DNA Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $667K in Q4 2020.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.